Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
8.25    0.00 (0.00%)
Bid:
7.50
Ask:
9.00
Spread: 1.50 (20.00%)
Market Cap: £19.50m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

EPA Ireland update

19 Sep 2025 16:55

RNS Number : 1240A
Symphony Environmental Tech. PLC
19 September 2025
 

 

19 September 2025

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony", the "Company" or the "Group")

EPA Ireland Update

 

 

Symphony Environmental Technologies Plc (AIM:SYM), global specialists in technologies that make plastic and rubber products "smarter, safer and sustainable," is making this further update.

 

On 8th July 2025 Symphony announced that it had received confirmation from the Environmental Protection Agency of Ireland ("EPA") as follows:

 

"We can confirm that d2w products do not fall within the scope of the Single-use Plastics Directive (EU) 2019/904, which prohibits the use of certain plastic materials due to their contribution to microplastic pollution. The d2w technology has been scientifically demonstrated to undergo full biodegradation without leaving behind persistent microplastics or toxic residues. This conclusion is supported by independent studies and aligns with the objectives of the Directive to reduce plastic pollution and promote sustainable alternatives."

 

Furthermore, the EPA said "we have reviewed the Commission Notice (2021/C 216/01) published in the Official Journal of the European Union on 7 June 2021, which provides Guidelines on the implementation of the Directive. Based on the evidence submitted, we are satisfied that d2w products are not subject to the restrictions outlined in the Directive or its accompanying Guidelines."

 

Symphony has now been informed by the EPA that it has no function to issue an assurance that a product is outside the scope of Article 5 of Directive (EU) 2019/904, and Symphony has received an apology. In Symphony's view it follows that the EPA has no function to decide whether a product is within the scope of Article 5, but officials in the EPA consider that they should follow the Guidelines, which in their view bring d2w plastic products within the scope of Article 5.

 

The EPA has however accepted that these Guidelines are not legally binding and has not disputed that they were written without the benefit of subsequent scientific evidence. It has also accepted that the General Court of the EU (in the case brought by Symphony against the EU Institutions) "did not make a determination as to whether the [d2w] Product is oxo-degradable plastic or not."

 

For the following reasons Symphony considers that the Guidelines are demonstrably incorrect: Recital 15 says "this Directive should cover products made from oxo-degradable plastic, as that type of plastic does not properly biodegrade and thus contributes to microplastic pollution in the environment." It follows therefore that plastics that have been scientifically demonstrated to undergo full biodegradation without leaving persistent microplastics or toxic residues are not oxo-degradable plastic for the purposes of the Directive.

 

The EPA has not changed its earlier position that "d2w technology has been scientifically demonstrated to undergo full biodegradation without leaving behind persistent microplastics or toxic residues."

 

As to Art.3(3) of the Directive, the EPA has not disputed the scientific evidence produced to it that (a) the d2w masterbatch does not "lead to" anything - as the process of oxidation would occur anyway, and even if it did (b) the plastic does not fragment into microplastics, and (c) there is no chemical decomposition. 

 

Symphony has been advised by Mr. Josh Holmes KC that the Directive can and should be interpreted so as to allow products made with d2w technology to be placed on the market in the EU.

 

 

 

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus (Nominated Adviser and Broker)

David Foreman, Emma Burn (Investment Banking)

Tel: +44 (0) 203 829 5000

NOTES TO EDITORS

 

About Symphony Environmental

 

 

Symphony's d2w masterbatch technology is added to polyethylene (PE) and polypropylene (PP) products at the manufacturing stage at little or no extra cost, and ensures that if they get into the environment at the end of their useful life they will not create microplastics and lie or float around for decades. Instead they will safely biodegrade, leaving no microplastics or toxicity. If they get collected during their useful life they can be recycled with ordinary PE and PP without separation See https://www.biodeg.org/subjects-of-interest/recycling-2/

 

Symphony also supplies a range of plastic technologies under its d2p (designed to protect) brand www.d2p.net to provide protection against insects, viruses, bacteria, fungi, rodents, odours, and fire. It has also introduced a new product under its NbR brand https://www.symphonyenvironmental.com/natural-biodegradable-resin/ to reduce the amount of fossil-derived material in plastic products.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is certified according to ISO9001 and ISO14001.

 

Symphony actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram and Linkedin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUPABUPAGAB
Date   Source Headline
20th Apr 20227:00 amRNSSymphony India Sustainability Award
30th Mar 20227:00 amRNSPreliminary results
24th Feb 20223:49 pmRNSExtension of options
23rd Feb 20227:00 amRNSNew US Supply Contract
17th Dec 20212:09 pmRNSTrading and business update
29th Nov 20217:00 amRNSPositive DEFRA consultation
19th Nov 20212:54 pmRNSDirector/PDMR Shareholding - options amendment
19th Nov 20212:11 pmRNSDirector/PDMR Shareholding - option amendments
19th Nov 20218:24 amRNSExpansion into India
12th Nov 20213:04 pmRNSSmall Cap Awards: ESG Company of the Year
25th Oct 20217:00 amRNSExclusive Distribution Agreement
5th Oct 20219:58 amRNSHolding(s) in Company
24th Sep 20217:00 amRNSEquity subscription and grant of warrants
16th Sep 20217:00 amRNSInterim results
3rd Sep 20217:00 amRNSHealth Canada approves d2p for bread packaging
2nd Aug 20217:30 amRNSNew agreements with Meditech
27th Jul 20213:00 pmRNSHolding(s) in Company
14th Jul 20217:00 amRNSNew expanded FDA approval for d2p food packaging
13th Jul 20217:00 amRNSTrading update
28th Jun 202111:56 amRNSResult of AGM
11th Jun 202110:04 amRNSHolding(s) in Company
9th Jun 20217:00 amRNSPDMR Dealing
3rd Jun 20217:00 amRNSPosting of accounts & notice of AGM
13th May 20217:00 amRNSEU legal challenge update
23rd Apr 20217:32 amRNSd2p anti-microbial technology to protect commuters
13th Apr 20212:40 pmRNSDirector Dealing
1st Apr 20213:23 pmRNSDirector Dealing
31st Mar 20217:00 amRNSPreliminary results
30th Mar 20217:00 amRNSCompletion of 5 year Oxomar study re. d2w
12th Mar 20217:00 amRNSEU legal challenge update
9th Feb 20217:00 amRNSTrading update
21st Dec 20207:00 amRNSEU legal action
30th Nov 20207:00 amRNSPositive Coronavirus Test Results of d2p products
16th Nov 20207:00 amRNSNew d2p product launch
9th Nov 20204:40 pmRNSSecond Price Monitoring Extn
9th Nov 20204:36 pmRNSPrice Monitoring Extension
30th Oct 20207:00 amRNSLaunch of d2p and d2w enhanced drinking straws
20th Oct 20207:00 amRNSCompletion of Eranova project financing
19th Oct 20207:00 amRNSLargest Bakery in Turkey Launches d2w Packaging
9th Oct 20207:00 amRNSExtension of Options
5th Oct 20205:52 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSUK Airport Group introduces d2w biodegradable bag
22nd Sep 20207:00 amRNSCotripal launches d2p and d2w shopping bags
16th Sep 20207:00 amRNSInvestor Meet Company presentation
15th Sep 20207:00 amRNSExercise of warrants
14th Sep 20204:40 pmRNSSecond Price Monitoring Extn
14th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:01 amRNSPositive Coronavirus test results
14th Sep 20207:00 amRNSInterim results
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.